These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11896686)

  • 21. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
    Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
    J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard.
    Boal JH; Williamson M; Boyd VL; Ludeman SM; Egan W
    J Med Chem; 1989 Aug; 32(8):1768-73. PubMed ID: 2754703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does acrolein contribute to the cytotoxicity of cyclophosphamide?
    Wrabetz E; Peter G; Hohorst HJ
    J Cancer Res Clin Oncol; 1980; 98(2):119-26. PubMed ID: 7217177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification.
    Ludeman SM; Shulman-Roskes EM; Wong KK; Han SY; Anderson LW; Strong JM; Colvin OM
    J Pharm Sci; 1995 Apr; 84(4):393-8. PubMed ID: 7629726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of O6-methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice.
    Hansen RJ; Nagasubramanian R; Delaney SM; Samson LD; Dolan ME
    Carcinogenesis; 2007 May; 28(5):1111-6. PubMed ID: 17116724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of binding of three aldehyde compounds with DNA using high performance liquid chromatograph].
    Feng B; Shao H; Zhang H
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Feb; 26(2):86-8. PubMed ID: 18445316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
    Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
    J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and characterization of O6-(2-chloroethyl)guanine: a putative intermediate in the cytotoxic reaction of chloroethylnitrosoureas with DNA.
    Parker S; Kirk MC; Ludlum DB
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1124-8. PubMed ID: 3689390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.
    Schwerdt G; Gordjani N; Benesic A; Freudinger R; Wollny B; Kirchhoff A; Gekle M
    Pediatr Nephrol; 2006 Jan; 21(1):60-7. PubMed ID: 16267686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenine N3 is a main alkylation site of styrene oxide in double-stranded DNA.
    Koskinen M; Vodicka P; Hemminki K
    Chem Biol Interact; 2000 Jan; 124(1):13-27. PubMed ID: 10658899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide toxicity in cultured proximal renal tubule cells.
    Springate J; Taub M
    Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
    Low JE; Borch RF; Sladek NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.
    Kurowski V; Wagner T
    Cancer Chemother Pharmacol; 1993; 33(1):36-42. PubMed ID: 8269587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro.
    Pieper RO; Futscher BW; Erickson LC
    Carcinogenesis; 1989 Jul; 10(7):1307-14. PubMed ID: 2736721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic acid alkylation by free radical metabolites of ethanol. Formation of 8-(1-hydroxyethyl)guanine and 8-(2-hydroxyethyl)guanine adducts.
    Nakao LS; Augusto O
    Chem Res Toxicol; 1998 Aug; 11(8):888-94. PubMed ID: 9705750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactions of nitrogen mustards with DNA.
    Hemminki K; Kallama S
    IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
    Huang Z; Waxman DJ
    Anal Biochem; 1999 Aug; 273(1):117-25. PubMed ID: 10452807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamide.
    Flowers JL; Ludeman SM; Gamcsik MP; Colvin OM; Shao KL; Boal JH; Springer JB; Adams DJ
    Cancer Chemother Pharmacol; 2000; 45(4):335-44. PubMed ID: 10755323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactions of nucleosides with glyoxal and acrolein.
    Shapiro R; Sodum RS; Everett DW; Kundu SK
    IARC Sci Publ; 1986; (70):165-73. PubMed ID: 3793171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and study of a spin-labeled cyclophosphamide analogue, 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide.
    Tsui FP; Robey FA; Engle TW; Ludeman SM; Zon G
    J Med Chem; 1982 Sep; 25(9):1106-10. PubMed ID: 7131492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.